February 12, LMI, DNB Healthcare, AbbVie, Novartis and Pfizer hosts a one day seminar called A partnership for life in 2015 - How to develop a strong Norwegian biotechnology and health industry sector?
The technology allows for the development of new and more efficient vaccines as well as new versions of existing vaccines with a need for improved efficacy.
Meltwater Newsfeed :
- Lungekreft mer dødelig enn brystkreft for kvinner January 27, 2015
- Ultimovacs completes venture financing January 26, 2015
- Ultimovacs carries out NOK 45 million share issue with Canica AS and Sundt AS as the main investors January 22, 2015
- Hagen satser millioner i Gjelstens kreftvaksine-selskap - DN.no January 22, 2015